Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers

Respiralab

Status: Completed

Conditions: Adverse Drug Event

Treatments: Biological: Pfizer-BioNTech COVID-19 vaccine

Study type: Observational

Funder types: Other

Identifiers

NCT05113472

2021-MED-001

Details and patient eligibility

About

Limited large-scale studies have been conducted to investigate the adverse effects of COVID-19 vaccine in Latin America, particularly among the healthcare worker (HCW) population in Ecuador. The objective of this study was to assess a cohort of Ecuadorian healthcare workers for adverse reactions following vaccination with the Pfizer-BioNTech vaccine.

Full description

The COVID-19 pandemic bears a burden on medical care and economies worldwide, however immunization at the population level provides a way for to reduce future morbidity and mortality. Vaccine hesitancy and reluctance in getting the COVID-19 vaccine and apprehensions about them have been present along the course of vaccination programs and mass immunizations across the world. Factors such as the quick, large-scale production of vaccines, lack of information, and uncertainty about adverse reactions in the public's eye as well about myths spreading through media channels have given rise to suspicion and fear in the Latin American population. Limited large-scale studies have been conducted to investigate the adverse effects of COVID-19 vaccine in Latin America, particularly among the healthcare worker (HCW) population in Ecuador. The objective of this study was to assess a cohort of Ecuadorian healthcare workers for adverse reactions following vaccination with the Pfizer-BioNTech vaccine.

Enrollment: 1,291 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ecuadorian nationality
• Active practice in the medical field
• Received the Pfizer-BioNTech COVID-19 vaccine

Exclusion criteria

• Patients who voluntarily refused to participate.

Trial design

1,291 participants in 1 patient group

Ecuadorian Healthcare Workers

Description:

All individuals involved were part of the first phase of the national COVID-19 vaccination plan in our country and were contacted through a local registry established by a local private university.

Treatment:

Biological: Pfizer-BioNTech COVID-19 vaccine